The reported statements, read against the company's own industry.
Financials view
Market Capitalization
1.77BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue (TTM)
552.16MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Profit Margin
-0.83%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Beta
1.25x
vs all stocks
Updated Jul 18, 2026
52-Week Change
19.53%
vs all stocks
Updated Jul 18, 2026
Market Capitalization
1.77BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Enterprise Value
1.68BUSD
vs all stocks (USD)
Updated Jul 18, 2026
Forward P/E
102.15x
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Price to Sales (TTM)
3.27x
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Price to Book (MRQ)
3.67x
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Enterprise to Revenue
3.04x
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Enterprise to EBITDA
94.51x
vs Medical Instruments & Supplies peers
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 72.13×.Updated Jul 18, 2026
Gross Margin
77.39%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Profit Margin
-0.83%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Operating Margin
0.37%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Return on Assets (TTM)
-0.30%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Return on Equity (TTM)
-0.97%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Revenue (TTM)
552.16MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Revenue per Share (TTM)
11.51USDUpdated Jul 18, 2026
Quarterly Revenue Growth
14.30%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Gross Profit (TTM)
417.46MUSD
vs all stocks (USD)
Updated Jul 18, 2026
EBITDA (TTM)
23.26MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Net Income (TTM)
-4.59MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Quarterly Earnings Growth (YoY)
14.26%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Operating Cash Flow (TTM)
64.36MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Levered Free Cash Flow (TTM)
41.06MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Trailing Annual Dividend Rate
0.00USDUpdated Jul 18, 2026
Trailing Annual Dividend Yield
0.00%
vs all stocks
Updated Jul 18, 2026
Payout Ratio
0.00%
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Revenue
534.53MUSDFY2025 · Dec 31, 2025
Cost of Goods Sold
133.75MUSDFY2025 · Dec 31, 2025
Gross Profit
400.78MUSDFY2025 · Dec 31, 2025
Operating Income
-9.45MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
-10.16MUSDFY2025 · Dec 31, 2025
Income Tax Expense
1.28MUSDFY2025 · Dec 31, 2025
Net Income
-11.45MUSDFY2025 · Dec 31, 2025
EBIT
-4.29MUSDFY2025 · Dec 31, 2025
EBITDA (Income Statement)
16.25MUSDFY2025 · Dec 31, 2025
Research & Development
99.21MUSDFY2025 · Dec 31, 2025
Selling, General & Administrative
311.02MUSDFY2025 · Dec 31, 2025
Non-operating Interest Income
4.48MUSDFY2025 · Dec 31, 2025
Non-operating Interest Expense
5.88MUSDFY2025 · Dec 31, 2025
EPS (Basic)
-0.2400USDFY2025 · Dec 31, 2025
EPS (Diluted)
-0.2400USDFY2025 · Dec 31, 2025
Basic Shares Outstanding
47.75MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
47.75MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
-11.45MUSDFY2025 · Dec 31, 2025
Operating Cash Flow
50.34MUSDFY2025 · Dec 31, 2025
Free Cash Flow
41.29MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
167.43MUSDFY2025 · Dec 31, 2025
Income Tax Paid
1.29MUSDFY2025 · Dec 31, 2025
Interest Paid
5.25MUSDFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
-11.45MUSDFY2025 · Dec 31, 2025
Depreciation & Amortization
20.53MUSDFY2025 · Dec 31, 2025
Stock-based Compensation
44.69MUSDFY2025 · Dec 31, 2025
Other Non-cash Items
7.85MUSDFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-5.61MUSDFY2025 · Dec 31, 2025
Change in Accounts Payable (CF)
-960.00KUSDFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-4.71MUSDFY2025 · Dec 31, 2025
Capital Expenditures
-9.05MUSDFY2025 · Dec 31, 2025
Net Intangibles (CF)
-6.00MUSDFY2025 · Dec 31, 2025
Sale of Investments
0.00USDFY2025 · Dec 31, 2025
Other Investing Activity
500.00KUSDFY2025 · Dec 31, 2025
Net Investing Cash Flow
-8.55MUSDFY2025 · Dec 31, 2025
Long-term Debt Issuance
0.00USDFY2025 · Dec 31, 2025
Long-term Debt Payments
-1.20MUSDFY2025 · Dec 31, 2025
Common Stock Repurchase
-11.16MUSDFY2025 · Dec 31, 2025
Common Dividends Paid
0.00USDFY2025 · Dec 31, 2025
Other Financing Charges
6.25MUSDFY2025 · Dec 31, 2025
Net Financing Cash Flow
-6.11MUSDFY2025 · Dec 31, 2025
Shares Outstanding
50.63MSharesUpdated Jul 18, 2026
Float Shares
48.55MSharesUpdated Jul 18, 2026
Shares Short
4.45MSharesUpdated Jul 18, 2026
Short Ratio
4.54days
vs all stocks
Updated Jul 18, 2026
Short % of Shares Outstanding
9.15%
vs all stocks
Updated Jul 18, 2026
% Held by Insiders
3.86%
vs all stocks
Updated Jul 18, 2026
% Held by Institutions
102.21%
vs all stocks
Updated Jul 18, 2026
Total Cash (MRQ)
146.16MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Cash per Share (MRQ)
2.89USDUpdated Jul 18, 2026
Total Debt (MRQ)
74.91MUSD
vs all stocks (USD)
Updated Jul 18, 2026
Total Debt to Equity (MRQ)
0.1524x
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Current Ratio (MRQ)
4.29x
vs Medical Instruments & Supplies peers
Updated Jul 18, 2026
Book Value per Share (MRQ)
9.71USDUpdated Jul 18, 2026
Total Assets
654.18MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
322.52MUSDFY2025 · Dec 31, 2025
Total Liabilities
162.24MUSDFY2025 · Dec 31, 2025
Total Non-current Assets
331.66MUSDFY2025 · Dec 31, 2025
Total Non-current Liabilities
80.72MUSDFY2025 · Dec 31, 2025
Total Current Liabilities
81.52MUSDFY2025 · Dec 31, 2025
Cash & Cash Equivalents
167.43MUSDFY2025 · Dec 31, 2025
Accounts Receivable
66.65MUSDFY2025 · Dec 31, 2025
Inventory
78.49MUSDFY2025 · Dec 31, 2025
Accounts Payable
25.31MUSDFY2025 · Dec 31, 2025
Other Current Liabilities
3.12MUSDFY2025 · Dec 31, 2025
Long-term Debt
73.38MUSDFY2025 · Dec 31, 2025
Other Non-current Liabilities
7.34MUSDFY2025 · Dec 31, 2025
Common Stock (Book)
50.00KUSDFY2025 · Dec 31, 2025
Retained Earnings
-413.20MUSDFY2025 · Dec 31, 2025
Total Shareholders' Equity
491.94MUSD
vs all stocks (USD)
FY2025 · Dec 31, 2025
52-Week Low
25.36USDUpdated Jul 18, 2026
52-Week High
43.18USDUpdated Jul 18, 2026
52-Week Change
19.53%
vs all stocks
Updated Jul 18, 2026
Beta
1.25x
vs all stocks
Updated Jul 18, 2026
50-Day MA
28.97USDUpdated Jul 18, 2026
200-Day MA
33.05USDUpdated Jul 18, 2026
Avg 10-Day Volume
778.15KSharesUpdated Jul 18, 2026
Avg 30-Day Volume
932.27KSharesUpdated Jul 18, 2026
Diluted EPS (TTM)
-0.1000USDUpdated Jul 18, 2026
Other Income / Expense
683.00KUSDFY2025 · Dec 31, 2025
1 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Equity looks heavy for the industry, but much of it is goodwill from past acquisitions.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Structural Tensions
High gross margins eroded by operating costsNotable
Gross Margin: 0.77Profit Margin: -0.01
Financial Health
Altman Z-Score 6.9: safe zoneNotable
Altman Z-Score: 6.90
Supply Chain
Upstream position: supplies 5 industries, depends on 1Notable
Outgoing: 5.00Incoming: 1.00
Scale
Market cap is $1.77B, above the global median of $1.15BNotable
Market cap (USD): 1,769,901,901Global Median: 1,146,734,693.424
Revenue is $552.16M, above the global median of $520.53MNotable